Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03629756
Title A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale Arizona 85258 United States Details
University of California, Los Angeles Los Angeles California 90024 United States Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Rocky Mountain Cancer Centers (Midtown) Denver Colorado 80218 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
QUEST Research Institute Royal Oak Michigan 48073 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
Prisma Health Greenville South Carolina 29605 United States Details
Texas Oncology, P.A. - Fort Worth Cancer Center Fort Worth Texas 76104 United States Details
Texas Oncology, P.A. - San Antonio Medical Center San Antonio Texas 78240 United States Details
Texas Oncology, P.A. - Tyler Tyler Texas 75702 United States Details
Medical Oncology Associates dba Summit Cancer Centers Spokane Washington 99208 United States Details
St. George Private Hospital Kogarah New South Wales 2217 Australia Details
Gallipoli Medical Research Foundation Greenslopes Queensland 4120 Australia Details
Cabrini Health Limited Malvern 3144 Australia Details
*Shaded cells indicate that there was no data available from for the field